nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery
|
Jackson, Cody B. |
|
|
19 |
C |
p. 496-506 |
artikel |
2 |
Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors
|
Bates, Rhiannon |
|
|
19 |
C |
p. 236-249 |
artikel |
3 |
A Generic Assay to Detect Aberrant ARSB Splicing and mRNA Degradation for the Molecular Diagnosis of MPS VI
|
Broeders, Mike |
|
|
19 |
C |
p. 174-185 |
artikel |
4 |
A Methodology for Assessing Tumor Clonality of Adult T Cell Leukemia/Lymphoma
|
Yamakawa, Tomohiro |
|
|
19 |
C |
p. 467-473 |
artikel |
5 |
A Novel Proteomic Method Reveals NLS Tagging of T-DM1 Contravenes Classical Nuclear Transport in a Model of HER2-Positive Breast Cancer
|
Lacasse, Vincent |
|
|
19 |
C |
p. 99-119 |
artikel |
6 |
A qPCR Method for AAV Genome Titer with ddPCR-Level of Accuracy and Precision
|
Wang, Yu |
|
|
19 |
C |
p. 341-346 |
artikel |
7 |
Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies
|
Mietzsch, Mario |
|
|
19 |
C |
p. 362-373 |
artikel |
8 |
Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector Production
|
Kurasawa, James H. |
|
|
19 |
C |
p. 330-340 |
artikel |
9 |
Clinical Development of Gene Therapies: The First Three Decades and Counting
|
Lapteva, Larissa |
|
|
19 |
C |
p. 387-397 |
artikel |
10 |
CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
|
Mathiesen, Sophie N. |
|
|
19 |
C |
p. 447-458 |
artikel |
11 |
Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV
|
Urak, Ryan Z. |
|
|
19 |
C |
p. 285-294 |
artikel |
12 |
CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity
|
Preece, Roland |
|
|
19 |
C |
p. 149-161 |
artikel |
13 |
Development and Optimization of a Hydrophobic Interaction Chromatography-Based Method of AAV Harvest, Capture, and Recovery
|
McNally, David J. |
|
|
19 |
C |
p. 275-284 |
artikel |
14 |
Development of a Novel Competitive qRT-PCR Assay to Measure Relative Lentiviral Packaging Efficiency
|
Vamva, Eirini |
|
|
19 |
C |
p. 307-319 |
artikel |
15 |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors
|
Ipseiz, Natacha |
|
|
19 |
C |
p. 375 |
artikel |
16 |
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
|
Powell, Allison B. |
|
|
19 |
C |
p. 78-88 |
artikel |
17 |
Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
|
Biswas, Moanaro |
|
|
19 |
C |
p. 347-361 |
artikel |
18 |
Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus
|
Rust, Blake J. |
|
|
19 |
C |
p. 438-446 |
artikel |
19 |
Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling Reactivation
|
Wada, Miho |
|
|
19 |
C |
p. 261-274 |
artikel |
20 |
High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
|
Belbellaa, Brahim |
|
|
19 |
C |
p. 120-138 |
artikel |
21 |
Identification of hsa-miR-1275 as a Novel Biomarker Targeting MECP2 for Human Epilepsy of Unknown Etiology
|
Zhao, Ye |
|
|
19 |
C |
p. 398-410 |
artikel |
22 |
In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
|
Wang, Sean K. |
|
|
19 |
C |
p. 376-386 |
artikel |
23 |
Investigational Assay for Haplotype Phasing of the Huntingtin Gene
|
Svrzikapa, Nenad |
|
|
19 |
C |
p. 162-173 |
artikel |
24 |
In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
|
Lenders, Malte |
|
|
19 |
C |
p. 24-34 |
artikel |
25 |
In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9
|
López-Manzaneda, Sergio |
|
|
19 |
C |
p. 426-437 |
artikel |
26 |
In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
|
Kwon, Jennifer B. |
|
|
19 |
C |
p. 320-329 |
artikel |
27 |
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
|
Soldi, Monica |
|
|
19 |
C |
p. 411-425 |
artikel |
28 |
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor
|
Powers, Alicia D. |
|
|
19 |
C |
p. 1-13 |
artikel |
29 |
Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
|
Tao, Rui |
|
|
19 |
C |
p. 507-517 |
artikel |
30 |
Machine Learning Enables Accurate Prediction of Asparagine Deamidation Probability and Rate
|
Delmar, Jared A. |
|
|
19 |
C |
p. 374 |
artikel |
31 |
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy Efficiency
|
Cao, Wenjing |
|
|
19 |
C |
p. 486-495 |
artikel |
32 |
Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
|
Barwe, Sonali P. |
|
|
19 |
C |
p. 201-209 |
artikel |
33 |
MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
|
Kong, Xiangyi |
|
|
19 |
C |
p. 295-306 |
artikel |
34 |
Nonclinical Studies that Support Viral Vector-Delivered Gene Therapies: An EFPIA Gene Therapy Working Group Perspective
|
Bolt, Michael W. |
|
|
19 |
C |
p. 89-98 |
artikel |
35 |
Optimization of S. aureus dCas9 and CRISPRi Elements for a Single Adeno-Associated Virus that Targets an Endogenous Gene
|
Backstrom, Jon R. |
|
|
19 |
C |
p. 139-148 |
artikel |
36 |
Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct
|
Chen, Yu Hua |
|
|
19 |
C |
p. 47-57 |
artikel |
37 |
Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes
|
Maeda, Takuya |
|
|
19 |
C |
p. 250-260 |
artikel |
38 |
Repeat Dosing of AAV2.5T to Ferret Lungs Elicits an Antibody Response That Diminishes Transduction in an Age-Dependent Manner
|
Tang, Yinghua |
|
|
19 |
C |
p. 186-200 |
artikel |
39 |
Safety and Efficacy of an Immune Cell-Specific Chimeric Promoter in Regulating Anti-PD-1 Antibody Expression in CAR T Cells
|
Fang, Yuan |
|
|
19 |
C |
p. 14-23 |
artikel |
40 |
Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
|
Masada, Kenta |
|
|
19 |
C |
p. 210-219 |
artikel |
41 |
Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector
|
Bobo, Tierra A. |
|
|
19 |
C |
p. 474-485 |
artikel |
42 |
Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model
|
Do, Tuan-Minh |
|
|
19 |
C |
p. 58-77 |
artikel |
43 |
The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles
|
Ma, Jinhu |
|
|
19 |
C |
p. 35-46 |
artikel |
44 |
Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9
|
Di Pasquale, Giovanni |
|
|
19 |
C |
p. 459-466 |
artikel |
45 |
WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
|
Muñoz, Pilar |
|
|
19 |
C |
p. 220-235 |
artikel |